OMNIAB, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
OMNIAB, INC. (OABI) had Debt Securities, Available-for-sale, Unrealized Loss Position of $19.26 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $19.26M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $14.83M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $9.59M.
- 2025-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $14.93M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $19.26M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $14.83M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $9.59M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $14.93M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $8.89M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.93M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.51M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $29.52M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $31.19M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $12.92M 10-K · filed 2025-03-18 |
| 2023-09-30 | $51.07M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $38.54M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $58.31M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $13.67M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |